nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—nerve—amyotrophic lateral sclerosis	0.0543	0.307	CbGeAlD
Carbidopa—DDC—hindbrain—amyotrophic lateral sclerosis	0.0406	0.23	CbGeAlD
Carbidopa—Trismus—Riluzole—amyotrophic lateral sclerosis	0.0356	0.0502	CcSEcCtD
Carbidopa—Dementia—Riluzole—amyotrophic lateral sclerosis	0.029	0.0409	CcSEcCtD
Carbidopa—DDC—embryo—amyotrophic lateral sclerosis	0.0254	0.144	CbGeAlD
Carbidopa—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0246	0.0347	CcSEcCtD
Carbidopa—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0239	0.0337	CcSEcCtD
Carbidopa—DDC—brainstem—amyotrophic lateral sclerosis	0.0233	0.132	CbGeAlD
Carbidopa—DDC—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0225	0.198	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.0219	0.193	CbGpPWpGaD
Carbidopa—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0276	CcSEcCtD
Carbidopa—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0248	CcSEcCtD
Carbidopa—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0244	CcSEcCtD
Carbidopa—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0237	CcSEcCtD
Carbidopa—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0237	CcSEcCtD
Carbidopa—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0223	CcSEcCtD
Carbidopa—DDC—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.0139	0.122	CbGpPWpGaD
Carbidopa—DDC—nervous system—amyotrophic lateral sclerosis	0.0122	0.069	CbGeAlD
Carbidopa—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0172	CcSEcCtD
Carbidopa—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0168	CcSEcCtD
Carbidopa—DDC—central nervous system—amyotrophic lateral sclerosis	0.0118	0.0664	CbGeAlD
Carbidopa—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0162	CcSEcCtD
Carbidopa—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0144	CcSEcCtD
Carbidopa—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.01	0.0141	CcSEcCtD
Carbidopa—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00965	0.0136	CcSEcCtD
Carbidopa—DDC—brain—amyotrophic lateral sclerosis	0.00933	0.0527	CbGeAlD
Carbidopa—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0126	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00895	0.0789	CbGpPWpGaD
Carbidopa—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00867	0.0122	CcSEcCtD
Carbidopa—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0122	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0122	CcSEcCtD
Carbidopa—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00857	0.0121	CcSEcCtD
Carbidopa—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0119	CcSEcCtD
Carbidopa—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00821	0.0116	CcSEcCtD
Carbidopa—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00812	0.0114	CcSEcCtD
Carbidopa—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00789	0.0111	CcSEcCtD
Carbidopa—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0108	CcSEcCtD
Carbidopa—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0105	CcSEcCtD
Carbidopa—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0069	0.00972	CcSEcCtD
Carbidopa—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00957	CcSEcCtD
Carbidopa—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00675	0.00952	CcSEcCtD
Carbidopa—Depression—Riluzole—amyotrophic lateral sclerosis	0.00664	0.00935	CcSEcCtD
Carbidopa—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00925	CcSEcCtD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00655	0.0578	CbGpPWpGaD
Carbidopa—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00652	0.00919	CcSEcCtD
Carbidopa—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00652	0.00919	CcSEcCtD
Carbidopa—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00912	CcSEcCtD
Carbidopa—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00621	0.00875	CcSEcCtD
Carbidopa—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00846	CcSEcCtD
Carbidopa—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00599	0.00844	CcSEcCtD
Carbidopa—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00842	CcSEcCtD
Carbidopa—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00594	0.00838	CcSEcCtD
Carbidopa—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00594	0.00838	CcSEcCtD
Carbidopa—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00831	CcSEcCtD
Carbidopa—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00825	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00535	0.0472	CbGpPWpGaD
Carbidopa—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00744	CcSEcCtD
Carbidopa—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00738	CcSEcCtD
Carbidopa—DDC—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00517	0.0456	CbGpPWpGaD
Carbidopa—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00722	CcSEcCtD
Carbidopa—Tension—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00719	CcSEcCtD
Carbidopa—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00718	CcSEcCtD
Carbidopa—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00712	CcSEcCtD
Carbidopa—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00709	CcSEcCtD
Carbidopa—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.005	0.00705	CcSEcCtD
Carbidopa—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00687	CcSEcCtD
Carbidopa—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00483	0.0068	CcSEcCtD
Carbidopa—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00677	CcSEcCtD
Carbidopa—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00674	CcSEcCtD
Carbidopa—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0067	CcSEcCtD
Carbidopa—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00661	CcSEcCtD
Carbidopa—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00657	CcSEcCtD
Carbidopa—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00656	CcSEcCtD
Carbidopa—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00648	CcSEcCtD
Carbidopa—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00644	CcSEcCtD
Carbidopa—Cough—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0064	CcSEcCtD
Carbidopa—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00635	CcSEcCtD
Carbidopa—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00633	CcSEcCtD
Carbidopa—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00624	CcSEcCtD
Carbidopa—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00622	CcSEcCtD
Carbidopa—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00616	CcSEcCtD
Carbidopa—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0061	CcSEcCtD
Carbidopa—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00603	CcSEcCtD
Carbidopa—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00598	CcSEcCtD
Carbidopa—Infection—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00594	CcSEcCtD
Carbidopa—Shock—Riluzole—amyotrophic lateral sclerosis	0.00418	0.00588	CcSEcCtD
Carbidopa—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00586	CcSEcCtD
Carbidopa—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00578	CcSEcCtD
Carbidopa—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0057	CcSEcCtD
Carbidopa—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00559	CcSEcCtD
Carbidopa—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00541	CcSEcCtD
Carbidopa—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00537	CcSEcCtD
Carbidopa—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00533	CcSEcCtD
Carbidopa—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00532	CcSEcCtD
Carbidopa—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00527	CcSEcCtD
Carbidopa—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0052	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00516	CcSEcCtD
Carbidopa—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00516	CcSEcCtD
Carbidopa—Pain—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00511	CcSEcCtD
Carbidopa—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00511	CcSEcCtD
Carbidopa—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00493	CcSEcCtD
Carbidopa—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00489	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00345	0.0304	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00345	0.0304	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00345	0.0304	CbGpPWpGaD
Carbidopa—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00475	CcSEcCtD
Carbidopa—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00473	CcSEcCtD
Carbidopa—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00473	CcSEcCtD
Carbidopa—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00441	CcSEcCtD
Carbidopa—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00429	CcSEcCtD
Carbidopa—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.003	0.00423	CcSEcCtD
Carbidopa—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00409	CcSEcCtD
Carbidopa—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00396	CcSEcCtD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.00276	0.0243	CbGpPWpGaD
Carbidopa—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0038	CcSEcCtD
Carbidopa—Rash—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00377	CcSEcCtD
Carbidopa—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00377	CcSEcCtD
Carbidopa—Headache—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00375	CcSEcCtD
Carbidopa—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00355	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00238	0.021	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00178	0.0157	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00131	0.0116	CbGpPWpGaD
Carbidopa—DDC—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00131	0.0116	CbGpPWpGaD
Carbidopa—DDC—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0012	0.0106	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00112	0.00985	CbGpPWpGaD
Carbidopa—DDC—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00105	0.00926	CbGpPWpGaD
Carbidopa—DDC—Metabolism—DAO—amyotrophic lateral sclerosis	0.00095	0.00838	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000892	0.00786	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000757	0.00667	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00072	0.00635	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSR—amyotrophic lateral sclerosis	0.000664	0.00586	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000546	0.00481	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000467	0.00412	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000293	0.00259	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000269	0.00238	CbGpPWpGaD
Carbidopa—DDC—Metabolism—APOE—amyotrophic lateral sclerosis	0.000222	0.00196	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000152	0.00134	CbGpPWpGaD
